Mifepristone (RU-486<sup>®</sup>) as a Schedule IV Controlled Drug-Implications for a Misleading Drug Policy on Women's Health Care. [PDF]
Int J Environ Res Public Health, 2022 Hsieh YP +4 more
europepmc +1 more source
If Supply-Oriented Drug Policy is Broken, Can Harm Reduction Help Fix It?—Melding Disciplines and Methods to Advance International Drug Control Policy [PDF]
Critics of the international drug control regime contend that supply-oriented policy interventions are not just ineffective, but they also produce unintended adverse consequences. Research suggests their claims have merit.
Letizia Paoli, Victoria A. Greenfield
core
Drug Overdose Rates Are Highest in Places With the Most Economic and Family Distress [PDF]
, 2018 In this brief, author Shannon Monnat examines county-level mortality data from the U.S. Centers for Disease Control and Prevention, pooled for 2006–2015, to gain insight into the U.S. drug overdose problem.
Monnat, Shannon M.
core +1 more source
DEL‐1 is an Endogenous Senolytic Protein that Inhibits Senescence‐Associated Bone Loss
Advanced Science, EarlyView.Senescent bone marrow stromal cells accumulate in the aging bone microenvironment, promoting bone degeneration. DEL‐1, an endogenous secreted protein, acts as a natural senolytic that selectively eliminates these cells. By engaging a β3 integrin/CD73/adenosine/p38 MAPK/BCL‐2 pathway, DEL‐1 counters aging‐related bone loss, revealing promising ...
Jong‐Hyung Lim +11 more
wiley +1 more source
UNGASS 2016 on drugs, the first challenge for HIV advocates in the post‐2015 era
Journal of the International AIDS Society, 2014 Ann Fordham, Khalid Tinasti
doaj +1 more source
Towards an ontological politics of drug policy: Intervening through policy, evidence and method.
The International journal on drug policy, 2020 K. Lancaster, T. Rhodes
semanticscholar +1 more source
Gαi1/3 Is a Novel Regulatory Target for RANKL Signal Transduction and Osteoporosis
Advanced Science, EarlyView.ABSTRACT Osteoporosis, characterized by progressive bone loss and increased fracture risk, is a growing concern as the population ages. Current treatments, though advanced, remain limited, underscoring the necessity for novel therapeutic targets. Recent studies have shown that the immune system plays a key role in osteoporosis, with osteoclasts driving
Chaowen Bai +15 more
wiley +1 more source
Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy [PDF]
Prescription drug expenditures make up less than 10 percent of total personal health care expenditures in the United States, but over the last decade the amount that Americans spend on prescription drugs has grown much faster than any other component of ...
Patricia M. Danzon, Stephen B. Soumerai
core
Advanced Science, EarlyView.Mature red blood cells (RBCs) can capture extracellular DNA, with short fragments homologous to cfDNA. This uptake is mediated by apoptotic bodies, which induce RBC oxidative stress, deformation, and accelerated in vivo clearance. The rbcDNA abundance correlates with tumor burden and therapeutic response, highlighting its potential as a liquid biopsy ...
Zihang Zeng +20 more
wiley +1 more source
Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China. [PDF]
BMC Health Serv Res, 2021 Peng Z +6 more
europepmc +1 more source